Streetbeat News

Analyst Ratings

PB

Truist Securities analyst Jennifer Demba maintains a 'Buy' rating on Prosperity Bancshares (NYSE:PB) but lowers the price target from $71 to $64.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 3:39 pm

PACW

Truist Securities analyst Brandon King maintains a 'Hold' rating on PacWest Banc (NASDAQ:PACW) and lowers the price target from $13 to $10.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 3:38 pm

OZK

Truist Securities analyst Brandon King has maintained a 'Hold' rating on Bank OZK (NASDAQ:OZK) and raised the price target from $38 to $43.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 3:38 pm

BAC

CFG

DB

GS

MS

NTRS

XLF

The Federal Reserve's 2023 stress tests showed that all 23 large U.S. banks have sufficient capital to absorb hypothetical losses of $540 billion in a severely adverse scenario. However, concerns remain over the vulnerability of certain banks to a collapse in the commercial real estate (CRE) market and unrealized fixed income losses. Goldman Sachs, Morgan Stanley, Citizens Financial Group, Northern Trust, and Deutsche Bank are among the most vulnerable to a CRE collapse. Bank of America is facing significant paper losses due to its decision to invest pandemic-era deposit inflows into debt markets.

Portfolio Pulse from Piero Cingari

June 29, 2023 | 3:38 pm

DLTR

Dollar Tree (NASDAQ:DLTR) is showing signs of a turnaround after years of stagnation, largely due to the introduction of multi-price assortments and the influence of activist investor Paul Hilal. The company's 2023 Investor Day revealed a promising plan for improving unit economics, primarily through increased sales per store and margin dollars.

Portfolio Pulse from The Science Of Hitting

June 29, 2023 | 3:37 pm

LOB

Truist Securities analyst Jennifer Demba maintains a 'Buy' rating on Live Oak Bancshares (NYSE:LOB) and raises the price target from $26 to $28.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 3:37 pm

IBTX

Truist Securities analyst Brandon King maintains a 'Buy' rating on Independent Bank Gr (NASDAQ:IBTX), but has lowered the price target from $43 to $40.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 3:36 pm

BNTX

BioNTech Inc.'s (NASDAQ:BNTX) shares are currently trading at $107.16, after a 0.24% increase. Over the past month, the stock has risen by 2.91%, but it has decreased by 31.97% over the past year. The company's P/E ratio of 3.81 is lower than the Biotechnology industry average of 50.29, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:33 pm

DIS

MU

NPWR

OPK

PFE

WING

Benzinga has released its top ratings upgrades, downgrades, and initiations for June 29, 2023. Upgrades include OPKO Health Inc, The RealReal Inc, Schneider National Inc, Intercept Pharmaceuticals Inc, FREYR Battery, Paramount Resources Ltd, and Micron Technology Inc. Downgrades include Symbotic Inc, Ashland Inc, RH, ContextLogic Inc, Citizens Financial Group Inc, Pfizer Inc, Inter & Co Inc, and The Walt Disney Co. New coverage initiations include NET Power Inc, Wingstop Inc, C3.ai Inc, Arlo Technologies Inc, CNO Financial Group Inc, Mister Car Wash Inc, Atlassian Corp, TJX Companies Inc, Ross Stores Inc, Instil Bio Inc, Establishment Labs Holdings Inc, Warner Music Group Corp, Corebridge Financial Inc, Generac Holdings Inc, Banco Latinoamericano de Comercio Exterior SA, Unity Software Inc, Academy Sports and Outdoors Inc, Hibbett Inc, Clarus Corp, Fox Factory Holding Corp, Quest Diagnostics Inc, Burlington Stores Inc, Freeport-McMoRan Inc, Tenaris SA, Roku Inc, Pentair PLC, Zurn Elkay Water Solutions Corp, Badger Meter Inc, Xylem Inc, and Gold Royalty Corp.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:02 pm

FWBI

Over the past three months, five analysts have given bullish ratings to First Wave BioPharma (NASDAQ:FWBI) with an average price target of $11.6, a decrease of 27.5% from the previous average price target of $16.00. No bearish or neutral ratings were reported.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 3:01 pm